retatrutide weight loss efficacy Effects of once-weekly subcutaneous on and metabolic markers: A systematic review and meta-analysis of randomized controlled trials retatrutide weight loss phase 2

It's important to note that there is considerable individual variation in how people respond to GLP-1 therapy

Therefore, ongoing medical supervision is essential when using this approach, and results related to microdosing should be interpreted with caution until more targeted research becomes available

Clinical data from the STEP 1 trial shows average weight loss of approximately 5.9 percent of baseline body weight at 12 weeks

Both are typically manageable with proper nutrition and guidance from your provider

This is often the first and only sign of gradual degradation that isn't visually apparent

Rather than relying only on thirst, many individuals build hydration into their routine through consistent water intake and electrolyte support